文献速递认知障碍与痴呆

阿尔茨海默病诊断与病理中的遗传韧性及抵抗性

Genetic Resilience and Resistance in Alzheimer's Disease Diagnosis and Pathology.
PubMed 文献 · Ann Neurol · 2026-09-22

研究探讨教育程度(EA)认知与非认知成分的多基因评分(GPS)与阿尔茨海默病(AD)诊断及神经病理的关联,纳入四个队列(两个活体生物标志物队列、两个尸检神经病理队列)。结果显示认知EA GPS与AD临床诊断及Braak分期显著负相关,而非认知EA GPS无显著关联,提示靶向认知成分的干预可能更具预防潜力。

要点

  • 认知成分EA GPS与AD临床诊断及Braak分期显著负相关。
  • 非认知成分EA GPS与AD诊断、血浆生物标志物及淀粉样PET无显著关联。
  • 单纯增加受教育年限的干预可能不影响AD发病率。

核心结论

  • 认知成分EA GPS与AD临床诊断及神经病理显著负相关,提示大脑维持机制支持抵抗神经元完整性改变。

研究设计与样本

  • 研究纳入四个队列:BioHermes-1(n=770)和ADNI(n=1,361)为活体生物标志物评估队列,ROSMAP(n=841)和BDR(n=511)为尸检神经病理评估队列。

主要发现

  • 认知EA GPS与AD临床诊断在所有四个队列中均呈显著负相关,并与ROSMAP和BDR队列的Braak分期显著负相关。
  • 非认知EA GPS与AD诊断、神经退行性血浆生物标志物、淀粉样PET状态及CERAD评分均无显著关联。

临床怎么用

  • 提示针对教育程度中认知成分(智力)的干预可能比单纯增加受教育年限更具AD预防潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Some individuals avoid Alzheimer's disease (AD) pathology as they age, or retain cognition despite substantial pathology, suggesting mechanisms of resistance or resilience to neurodegeneration. Educational attainment (EA) is associated with reduced risk of cognitive decline, although the underlying mechanisms remain unclear. We investigated whether genome-wide polygenic scores (GPS) based on cognitive and non-cognitive components of EA, reflecting intelligence and behavioral/social traits, respectively, show differential associations with AD diagnosis and neuropathology. METHODS: Associations between GPS for cognitive and non-cognitive components of EA and AD outcomes were examined across four cohorts: two cohorts included living participants with biomarker assessments (BioHermes-1, n = 770; Alzheimer's Disease Neuroimaging Initiative [ADNI], n = 1,361), and two included postmortem neuropathological evaluations (Religious Orders Study and Rush Memory and Aging Project [ROSMAP], n = 841; Brain for Dementia Research [BDR], n = 511). Outcomes included clinical diagnosis, amyloid status, plasma neurodegenerative biomarkers, and neuropathological measurements. RESULTS: We found a significant negative association between cognitive EA GPS and clinical diagnosis of AD across all four cohorts and with Braak stage in ROSMAP and BDR cohorts. In contrast, the GPS for non-cognitive component of EA showed no significant association with AD diagnosis, neurodegenerative plasma biomarkers or amyloid positron emission tomography (PET) status and the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) scores. INTERPRETATION: These results suggest a brain maintenance mechanism that supports the brain's ability to resist to changes in neuronal integrity. This indicates that interventions focused on increasing EA solely by additional years of schooling are unlikely to affect AD incidence, whereas alternative approaches targeting the cognitive component of EA (intelligence) may offer greater potential for prevention. ANN NEUROL 2026.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Leonenko G, Mavromati K, Hughes L, et al. Genetic Resilience and Resistance in Alzheimer's Disease Diagnosis and Pathology. Ann Neurol. 2026. PMID: 42770545. doi:10.1002/ana.78367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。